Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 1 4Phase 2 3

Status

Withdrawn 8Not yet recruiting 4Active not recruiting 4Recruiting 3Completed 3Terminated 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 2Myelodysplastic Syndromes 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × ALT-803 × Clear all
NCT04491955 2025-04-24

Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
32 enrolled 20 charts
Gastrointestinal

Colorectal Neoplasms

NCT02989844 2023-11-03

Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
20 enrolled 17 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03050216 2023-07-18

QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
8 enrolled 14 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡